Viewing Study NCT06624540



Ignite Creation Date: 2024-10-26 @ 3:41 PM
Last Modification Date: 2024-10-26 @ 3:41 PM
Study NCT ID: NCT06624540
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-09-12

Brief Title: Impact of Implementing Evidence-based Practice and Nurses Behavior Change to Improve Quality of Care in Intensive Care Unit in a Tertiary Hospital in Bangladesh
Sponsor: None
Organization: None

Study Overview

Official Title: Impact of Implementing Evidence-based Practice and Nurses Behavior Change to Improve Quality of Care in Intensive Care Unit in a Tertiary Medical College Hospital DMCH in Bangladesh
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EBP in Nursing
Brief Summary: Quality of care is crucial for preventing adverse events such as infection in the intensive care units ICUs The most common ICU-acquired infections include pneumonia such as ventilator-associated pneumonia VAP Central Line Bloodstream Infection CLABSI catheter-associated urinary tract in Medical Device Related Pressure Ulcer MDRPU and Pressure Ulcer PU This study explores the patient outcome in ICU by examining the causes and prevalence of ICU-acquired infection The implementation of evidence-based practice EBP to reduce infection and change the nurses practice behavioral changes to adhere with EBP based on simulation-based training

General objective

To evaluate the implementation of EBP by using recent technologies-based equipment to prevent VAP and promote behavior change among nurses for better outcome of the patient in ICU

Specific Objectives

1 Evaluate the efficacy of EBP including proper equipment-use for better patient outcomes in the ICU
2 Evaluate the effectiveness of EBP education by changing nurses behavior and determine its impact on improving patient outcomes in the ICU
3 Examine the feasibility of evaluation process and outcomes and successful implementation of EBP in ICU

Hypothesis

It is hypothesize that implementing EBP in ICU including new equipment use and nurses training will improve patient outcome

These research consist of three studies

Study 1 A prospective cohort study design will be applied to estimate the prevalence of adverse events VAP rate MDRPU rate PU rate CLABSI rate length of stay and survival rate in ICU The patients of General ICU will be followed up after admission up to discharge or death at ICU The investigators use the study findings for our subsequent intervention study 3 as historical data

Study 2 A pre- and post- quasi-experimental study will be conducted for 6 months to evaluate the nurses competency on EBP after getting 1-month EBP training This study has 3 phases 1 Pre-observation period to measure nurses competency level for 2-month 2 nurses EBP training period with preparation for 1 month and 3 post-implementation period to measure nurses competency and implementation of EBP practice for 2 months Study nurses will receive EBP training EBP and proper equipment for patient management The nurses will receive EBP education and training with necessary equipment such as a close suction catheter an endotracheal tube a suction device and a mouth care brush In this study use global standard equipment for the patients safety

Study 3 A pre- and post- quasi-experimental study will be implemented to evaluate the efficacy of EBP implementation The investigators use new equipment and implement EBP for patients and assess the patient outcomes The investigators compare the findings from study 1 as historical data with the data from this study 3

The investigators will compare the VAP infection prevalence and patients outcomes related to ICU-acquired infection between pre- and post- test phase
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None